Wird geladen...
SALL4 Immunoreactivity Predicts Prognosis in Western Hepatocellular Carcinoma Patients but is a Rare Event - A Study of 236 Cases
Prognostic biomarkers that stratify patients with cancer are needed. Recent studies from Asia have implicated SALL4, a stem cell marker, as useful in identifying aggressive cases of hepatocellular carcinoma (HCC), and over 50% of the cases tested had upregulation by microarray or dense immunoreactiv...
Gespeichert in:
| Veröffentlicht in: | Am J Surg Pathol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854193/ https://ncbi.nlm.nih.gov/pubmed/24805857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000000218 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|